These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26733554)

  • 1. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population.
    Merchant SJ; Nanji S; Brennan K; Karim S; Patel SV; Biagi JJ; Booth CM
    Cancer; 2017 Aug; 123(15):2840-2849. PubMed ID: 28346663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e29-e38. PubMed ID: 27663601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practice.
    Satkunam N; Wei X; Biagi JJ; Nanji S; Booth CM
    J Natl Compr Canc Netw; 2016 Dec; 14(12):1548-1554. PubMed ID: 27956539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based Study.
    Rodriguez L; Brennan K; Karim S; Nanji S; Patel SV; Booth CM
    Clin Colorectal Cancer; 2018 Dec; 17(4):e651-e661. PubMed ID: 30061036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
    Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
    Krishnamurthy A; Kankesan J; Wei X; Nanji S; Biagi JJ; Booth CM
    Eur J Surg Oncol; 2017 Feb; 43(2):364-371. PubMed ID: 27727025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.
    Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H
    Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
    Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
    Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
    Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study.
    Chandhoke G; Wei X; Nanji S; Biagi J; Peng Y; Krzyzanowska M; Mackillop WJ; Booth CM
    Ann Surg Oncol; 2016 Aug; 23(8):2529-38. PubMed ID: 26965700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
    André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
    J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
    Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
    J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population-based study of bladder cancer.
    Booth CM; Siemens DR; Wei X; Peng Y; Berman DM; Mackillop WJ
    BJU Int; 2015 Sep; 116(3):373-81. PubMed ID: 25168574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study].
    Mondaca S; Villalón C; Leal JL; Zúñiga Á; Bellolio F; Padilla O; Palma S; Garrido M; Nervi B
    Rev Med Chil; 2016 Feb; 144(2):145-51. PubMed ID: 27092667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.